People · Operator

David Lampach

Named in public records as an officer, director or promoter · active 2015–2018 · Biotechnology, Agriculture

2
Companies
4
Filings
$11.2M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Steep Hill, Inc.BiotechnologySeries A$10.1M$144.6M2015
California CannabinoidsAgricultureSeed$1.1M$11.6M2017
Operator network

David Lampach at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Mitchell Baruchowitz · 8 companies · 1 sharedMitchell Baruchow…Mitchell Kulick · 2 companies · 1 sharedMitchell KulickNigel Stobart · 2 companies · 1 sharedNigel StobartStephen DeAngelo · 2 companies · 1 sharedStephen DeAngeloAddison Demoura · 1 companies · 1 sharedAddison DemouraAndrew Rosenstein · 1 companies · 1 sharedAndrew RosensteinBrett Finkelstein · 1 companies · 1 sharedBrett FinkelsteinJeffrey Monat · 1 companies · 1 sharedJeffrey MonatJmichaele Keller · 1 companies · 1 sharedJmichaele KellerStephen Finfer · 1 companies · 1 sharedStephen FinferKen Rubin · 2 companies · 1 sharedKen RubinLeif Bierer · 1 companies · 1 sharedLeif BiererSheila Hoyt · 1 companies · 1 sharedSheila HoytSteep Hill, Inc. · $10.1M raisedSteep Hill, Inc.California Cannabinoids · $1.1M raisedCalifornia Cannabinoi…David LampachDL
David Lampach Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside David Lampach on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Mitchell Baruchowitz18
Nigel Stobart12
Mitchell Kulick12
Ken Rubin12
Stephen DeAngelo12
Brett Finkelstein11
Jmichaele Keller11
Sheila Hoyt11
Leif Bierer11
Addison Demoura11
Andrew Rosenstein11
Jeffrey Monat11
Stephen Finfer11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.